Annals of Hepatology

Contenido por año, Vol. y Num.

Índice de este artículo

Información General

Instrucciones para Autores

Mensajes al Editor


>Revistas >Annals of Hepatology >Año 2012, No. 3

Wen-Bin Y, En-Qiang C, Hong-Xia B, Lang B, Xue-Bin C, Ping F, Hong T
Different models in predicting the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure
Ann Hepatol 2012; 11 (3)

Idioma: Inglés
Referencias bibliográficas: 34
Paginas: 311-319
Archivo PDF: 131.07 Kb.

Texto completo


Sin resumen.

Palabras clave: Sin palabras Clave


  1. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-45.

  2. Merle P, Trepo C, Zoulim F. Current management strategies for hepatitis B in the elderly. Drugs & aging 2001; 18: 725-35.

  3. Sarin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2009; 3: 269-82.

  4. Katoonizadeh A, Laleman W, Verslype C, et al. Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. Gut 2010; 59: 1561-9.

  5. Graziadei IW. The clinical challenges of acute on chronic liver failure. Liver Int 2011; 31 (Suppl. 3): 24-6.

  6. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.

  7. O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45.

  8. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.

  9. Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-26.

  10. Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130: 1652-60.

  11. Huo TI, Wang YW, Yang YY, et al. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis. Liver Int 2007; 27: 498-506.

  12. Luca A, Angermayr B, Bertolini G, et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 2007; 13: 1174-80.

  13. Huo TI, Lin HC, Huo SC, et al. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis. Liver Transpl 2008; 14: 837-44.

  14. Zhang JY, Zhang FK, Wang BE, Jia JD, Zhang ST. The prognostic value of end-stage liver disease model in liver cirrhosis. Zhonghua Nei Ke Za Zhi 2005; 44: 822-4.

  15. Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 2003; 52: 134-9.

  16. Cho HC, Jung HY, Sinn DH, et al. Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte- Pugh, MELD and MELDNa score. Eur J Gastroenterol Hepatol 2011; 23: 51-9.

  17. Boursier J, Cesbron E, Tropet AL, Pilette C. Comparison and improvement of MELD and Child-Pugh score accuracies for the prediction of 6-month mortality in cirrhotic patients. J Clin Gastroenterol 2009; 43: 580-5.

  18. Jiang M, Liu F, Xiong WJ, Zhong L, Chen XM. Comparison of four models for end-stage liver disease in evaluating the prognosis of cirrhosis. World J Gastroenterol 2008; 14: 6546-50.

  19. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6: 163-9.

  20. Anand AC, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King’s criteria. J Hepatol 1997; 26: 62-8.

  21. Sun QF, Ding JG, Xu DZ, et al. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model. J Viral Hepat 2009; 16: 464-70.

  22. Radha Krishna Y, Saraswat VA, Das K, et al. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis. Liver Int 2009; 29: 392-8.

  23. He WP, Hu JH, Tong JJ, Liu FF, Wang HF. Comparison of MELD-Na versus MELDNa in the prediction of short-term prognosis for acute-on-chronic hepatitis B liver failure. Zhonghua Yi Xue Za Zhi 2011; 91: 1173-7.

  24. Zheng MH, Shi KQ, Fan YC, et al. A model to determine 3- month mortality risk in patients with acute-on-chronic hepatitis B liver failure. Clin Gastroenterol Hepatol 2011; 9: 351-356 e3.

  25. Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997; 337: 473-9.

  26. Christensen E, Schlichting P, Fauerholdt L, et al. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 1984; 4: 430-5.

  27. Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987; 7: 660-4.

  28. Li Q, Wang BE, Jia JD. The evolution and characteristics of liver function classification: from Child to MELD. Zhonghua Gan Zang Bing Za Zhi 2004; 12: 319-20.

  29. Freeman RB Jr., Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002; 8: 851-8.

  30. Cholongitas E, Papatheodoridis GV, Vangeli M, Terreni N, Patch D, Burroughs AK. Systematic review: The model for end-stage liver disease—should it replace Child- Pugh’s classification for assessing prognosis in cirrhosis? Alimentary pharmacology & therapeutics 2005; 22: 1079-89.

  31. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol 2005; 42(Suppl.): S100-S107.

  32. Cholongitas E, Marelli L, Shusang V, et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 2006; 12: 1049-61.

  33. Liu XY, Hu JH, Wang HF. Analysis of prognostic factors for patients with acute-on-chronic liver failure. Zhonghua Gan Zang Bing Za Zhi 2009; 17: 607-10.

  34. Huang K, Hu JH, Wang HF, et al. Survival and prognostic factors in hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 2011; 17: 3448-52.

>Revistas >Annals of Hepatology >Año2012, No. 3

· Indice de Publicaciones 
· ligas de Interes 

Derechos Resevados 2019